Delivery Order SPE2DB20D9214-SPE2DB25FD4UM

Award Date 4/28/25
Potential Completion Date 5/19/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,642.68 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with an ultimate completion date of October 4, 2024. The award is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $26,764.80, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract is a firm fixed-price delivery order that is not associated with any set-aside designation, allowing DMS Pharmaceutical Group to leverage its status as a woman-owned...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order valued at $17,771.40 with a firm fixed price pricing type. The contract covers the supply of 4567693307 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract is not...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $26,764.80, is for the delivery of 4,567,362,591 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,391.88 firm fixed-price contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a period of performance through March 29, 2024. The contract is not associated with a set-aside program. However, DMS Pharmaceutical Group's woman-owned small business...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,364.16 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a completion date of August 20, 2024. The award is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, with a ceiling value of $34,070.94, is for the delivery of 4,564,205,389 units of PROLASTIN C 1,000 MG/20 ML medication. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,920.50, is a firm fixed-price delivery order for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The contract is part of a larger indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which allows the DLA to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $17,712.00 firm fixed-price delivery order is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $16,192.44, is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialty pharmaceutical product. The award is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB with the DLA, worth up to $4,999,999 through the end of...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB25FD4UM
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price valued at $17,771.40 and has an ultimate completion date of May 19, 2025.

The contract is for the provision of 4,568,091,646 units of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide.

The contract does not have a set-aside designation, and DMS Pharmaceutical Group has consistently secured federal contracts without specific set-aside requirements, leveraging its status as a woman-owned small business. This positioning establishes DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites.

Generated 8/3/25, 12:48 AM